LL-37 (Cathelicidin Peptide)
LL-37 is your body's "First Responder & SWAT Team." It's a special protein that patrols your tissues. When it finds a "crime scene" (an infection or injury),...
Technical Overview
LL-37 is the only human cathelicidin peptide, a multifunctional host defense peptide and a key component of the innate immune system. Beyond its role as an antimicrobial, it acts as a potent signaling molecule for tissue regeneration and immune modulation.
⏱️ Pharmacokinetics
| Parameter | Value | Notes |
|---|---|---|
| Half-life | < 1 Hour | Rapidly degraded by proteases in serum |
| Tmax | ~30 Minutes | Peak plasma levels after SubQ or IV administration |
| Biological Window | 6 - 12 Hours | Downstream cytokine cascades (IFN-β) extend its effect [PMID: 40612001] |
Mechanism of Action
- Innate Immunity: Forms pores in bacterial cell membranes, leading to lysis. Potentiates viral-induced interferon β (IFN-β) expression in airway cells via a Calcium-dependent (Ca2+) mechanism [PMID: 40612001].
- Sepsis Protection: Directly binds and neutralizes lipopolysaccharides (LPS), protecting against lethal endotoxemia and sepsis-induced organ failure [PMID: 40960088].
- Tissue Repair: Stimulates angiogenesis and fibroblast migration, crucial for healing chronic or recalcitrant wounds.
Layman's Explanation
LL-37 is your body's "First Responder & SWAT Team." It's a special protein that patrols your tissues. When it finds a "crime scene" (an infection or injury), it doesn't just call for backup—it starts kicking down doors (killing bacteria) and rebuilding the neighborhood (healing blood vessels) immediately. Recent 2025 research shows it even "talks" to your cells using calcium signals to supercharge their natural defenses against viruses like the common cold or flu.
️ Demographic Warnings & Precautions
️ Obesity & Metabolic State
Metabolic Endotoxemia. Obese individuals often have higher levels of circulating LPS (bacterial toxins) from the gut. LL-37 may be "exhausted" neutralizing these systemic toxins, leaving less available for localized repair or infection control in the skin or lungs.
Elderly (Advanced Age)
Immunosenescence. As we age, the ability of our epithelial cells to produce LL-37 declines, increasing the risk of respiratory infections. Supplementing LL-37 is highly indicated for the elderly but must be balanced against the risk of exacerbating chronic inflammatory skin conditions.
️ Heart & Cardiovascular Conditions
Cardioprotection in Sepsis. In septic shock, LL-37 has been shown to protect the heart from inflammation-induced cardiomyopathy. However, in non-septic conditions, high levels may interfere with calcium signaling in heart tissue; use caution in patients with existing arrhythmias.
Upsides & Downsides
Upsides
- Broad Spectrum: Active against bacteria, viruses, and fungi.
- Wound Healing: Excellent for diabetic ulcers or non-healing surgical sites.
- Sepsis Defense: Life-saving potential in systemic inflammatory response syndrome (SIRS).
Downsides
- Autoimmune Trigger: Can exacerbate psoriasis and lupus by acting as an autoantigen.
- Cancer Risk: Known to promote growth in certain cancers (ovarian, lung) while suppressing others (colon). Use with caution if malignancy is suspected.
Synergies
- Vitamin D3: Vitamin D binds to the Vitamin D Receptor (VDR), which directly turns on the gene for LL-37 production (CAMP gene).
- Rhinovirus (RV): Synergizes with viral triggers to enhance the body's natural interferon-beta production [PMID: 40612001].
- Calcium (Ca2+): LL-37 requires calcium for its signaling potentiation in human epithelial cells.
Key References
- [PMID: 40612001] - Cerps S, et al. LL-37 increases rhinovirus-induced interferon β expression (2025).
- [PMID: 40960088] - Cathelicidin LL-37 in Sepsis: A Review (2025).
- [PMID: 20049649] - LL-37: The only human member of the cathelicidin family (2010).
- [PMID: 32927756] - The role of LL-37 in autoimmunity and inflammation (2020).